Tablon, Elena D.

HRN: 28-68-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/29/2026
04/05/2026
IV
250mg
Q48hrs
VAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: